Doral - Sleep Aid and Insomnia Treatment
Questcor - Doral - Sleep Aid for the Treatment of Insomnia
Questcor - Doral - Sleep Aid for the Treatment of Insomnia

Welcome to DoralForSleep.com

Many Americans have trouble falling asleep and staying asleep each night.

Doral® (quazepam tablets, USP) is a unique and highly effective sleep aid that has a low incidence of side effects.1,2

If you are experiencing sleep problems, it’s time to talk to your doctor about your treatment options. Doral may be right for you.

Doral is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.

Doral has been classified as a Schedule IV controlled substance.

Patients receiving Doral should be cautioned about possible combined effects with alcohol and other CNS depressants.

Please see full prescribing information and patient Medication Guide.

The product information provided in this site is intended only for residents of the United States.

References: 1. Kales A. Quazepam: hypnotic efficacy and side effects. Pharmacotherapy. 1990;10(1):1-12. 2. Doral [package insert]. Union City, Calif: Questcor Pharmaceuticals, Inc.: October 2010. 3. Kales A, Bixler EO, Vela-Bueno A, et al. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam. Clin Pharmacol Ther. 1986;40(4):378-386. 4. Rush CR, Armstrong DL, Ali JA, Pazzaglia PJ. Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects. J Clin Psychopharmacol. 1998;18(2):154-165.
Doral is under license from Baker Norton Pharmaceuticals Inc.
Questcor is a registered trademark of Questcor Pharmaceuticals, Inc.
© 1999-2011 Questcor Pharmaceuticals, Inc.